特莫斯膠囊 100 毫克
Country: Taiwan
Language: Chinese
Source: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
Patient Information leaflet
(PIL)
12-06-2020
Public Assessment Report
(PAR)
12-06-2020
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
TEMOZOLOMIDE;;TEMOZOLOMIDE;;TEMOZOLOMIDE
Available from:
美時化學製藥股份有限公司 台北市信義區松仁路277號17樓 (11456110)
ATC code:
L01AX03
Pharmaceutical form:
膠囊劑
Composition:
TEMOZOLOMIDE (1004002000) MG; TEMOZOLOMIDE (1004002000) MG; TEMOZOLOMIDE (1004002000) MG
Units in package:
玻璃瓶裝;;鋁箔小袋裝
Class:
製 劑
Prescription type:
須由醫師處方使用
Manufactured by:
美時化學製藥股份有限公司南投廠 南投縣南投市新興里成功一路３０號 TW
Therapeutic area:
temozolomide
Therapeutic indications:
新診斷的多形神經膠母細胞瘤，與放射治療同步進行，然後作為輔助性治療。給予標準治療後復發性或惡化之惡性神經膠質瘤，例如多形神經膠母細胞瘤或退行性星狀細胞瘤。
Product summary:
有效日期: 2026/05/24; 英文品名: Tamos Capsules 100 mg
Authorization date:
2011-05-24
Patient Information leaflet
CUSTOMER SIGNED PRINT PROOF APPROVAL FORM
CUSTOMER SIGNATURE
DATE
SAP CODE
ARTWORK CODE
ARTWORK VERSION
PAGE1 ( FOR GMP SPEC.)
METAM01
ARTDB017321P
Read the complete document
